---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-056064"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:01:12.689838+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q1 revenue up 4.1% to $1.665B; net income up 52.4%; declares $0.125 dividend

## Summary
- Revenue $1,665M (+4.1% YoY); net income $85.3M (+52.4%); EPS $0.56 (+51.3%).
- Adjusted EBITDA $214.1M (+30.6%); operating income $151.5M (+45.7%).
- Critical illness recovery hospital segment Adjusted EBITDA surged 113.5% to $76.8M; other segments also grew.
- Declared $0.125/share dividend payable May 31 to holders of record May 18.
- FY 2023 outlook: revenue $6.5B-$6.7B; Adjusted EBITDA $780M-$820M; EPS $1.75-$1.99.

## SEC filing metadata
- accession: 0001104659-23-056064
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465923056064/0001104659-23-056064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465923056064/tm2314609d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-056064
- JSON: https://secwatch.observer/filing/0001104659-23-056064.json
- Plain text: https://secwatch.observer/filing/0001104659-23-056064.txt

## Key facts
- Earnings Releases
  SELECT MEDICAL HOLDINGS CORP reported first quarter ended March 31, 2023 results: revenue $1,665.0 million, net income $85.3 million, EPS $0.56.
  - Period: first quarter ended March 31, 2023
  - Revenue: $1,665.0 million
  - Net income: $85.3 million
  - EPS: $0.56
  - Result: reported results
  source text: For the first quarter ended March 31, 2023, revenue increased 4.1% to $1,665.0 million, compared to $1,599.5 million for the same quarter, prior year. Income from operations increased 45.7% to $151.5 million for the first quarter ended March 31, 2023, compared to $104.0 million for the same quarter, prior year. Net income increased 52.4% to $85.3 million for the first quarter ended March 31, 2023, compared to $55.9 million for the same quarter, prior year. Adjusted EBITDA increased 30.6% to $214.1 million for the first quarter ended March 31, 2023, compared to $163.8 million for the same quarter, prior year. Earnings per common share increased 51.3% to $0.56 for the first quarter ended March 31, 2023, compared to $0.37 for the same quarter, prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320414/000110465923056064/0001104659-23-056064-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.